A 58-year-old man with poorly controlled type 2 diabetes (HbA1c 9.1%) and established coronary artery disease is on maximally tolerated metformin and ...

Question

A 58-year-old man with poorly controlled type 2 diabetes (HbA1c 9.1%) and established coronary artery disease is on maximally tolerated metformin and a sulfonylurea. According to the 2024 Diabetes Canada pharmacotherapy update, which additional agent class is most appropriate to improve cardiovascular and renal outcomes?

Accepted Answer

SGLT2 inhibitor

Answer

Thiazolidinedione

Answer

Basal insulin only

Answer

Acarbose

Answer

Short-acting insulin secretagogue

ca-mccqe1 MCQ (SBA): Type 2 diabetes with ASCVD